Streetbeat News

Analyst Ratings

LRCX

A significant bearish stance has been taken on Lam Research (NASDAQ:LRCX) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 21% bullish and 78% bearish. The whales have been targeting a price range from $320.0 to $720.0 for Lam Research over the last 3 months. Several financial institutions have maintained their positive ratings on Lam Research, with price targets ranging from $680 to $800.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 7:00 pm

CRC

In the last quarter, California Resources (NYSE:CRC) received 7 bullish analyst ratings with an average price target of $62.43, indicating an upside from the current price of $55.5. The average price target has increased by 11.48% over the past month.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 7:00 pm

CRM

GOOG

GOOGL

MSFT

NVDA

PLTR

Nvidia Corp (NASDAQ:NVDA) is set to report earnings on Aug. 23, with expectations that strong results could ignite a tech rally. Wedbush analyst Dan Ives believes Nvidia's earnings could fuel a move higher in tech for the rest of the year, and that the company could be on pace to double its revenues over the next two years. Nvidia's earnings will also impact other AI leaders like Microsoft Corp (NASDAQ:MSFT) and Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL), as well as Salesforce Inc (NYSE:CRM) and Palantir Technologies Inc (NYSE:PLTR).

Portfolio Pulse from Adam Eckert

August 21, 2023 | 7:00 pm

NVRO

Over the last quarter, 21 analysts have provided ratings for Nevro (NYSE:NVRO), with 2 being bullish, 6 somewhat bullish, and 13 indifferent. The average 12-month price target for Nevro is $32.29, representing an 18.69% decrease from the previous average price target of $39.71.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 7:00 pm

AMAT

Over the past 3 months, 16 analysts have published their opinion on Applied Mat (NASDAQ:AMAT) stock. The majority of these ratings are bullish, with an average price target of $157.62, indicating potential upside from the current price of $148.165. The average price target has increased by 11.1% over the past month.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 7:00 pm

FTCH

Over the past 3 months, 9 analysts have published their opinion on Farfetch (NYSE:FTCH) stock. The current average price target represents a 33.96% decrease from the previous average price target of $8.04. The ratings include 1 bullish, 2 somewhat bullish, 4 indifferent, and 2 bearish.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 7:00 pm

EXEL

IPSEY

RHHBY

Exelixis Inc, Roche Holdings AG, and Ipsen announced that their Phase 3 CONTACT-02 pivotal trial evaluating Cabometyx in combination with Tecentriq has met one of the primary endpoints, showing a significant improvement in progression-free survival. The trial is for patients with metastatic castration-resistant prostate cancer. The estimated total U.S. market value is approximately $1.9 billion. Analysts from William Blair maintain the Outperform rating on Exelixis' stock.

Portfolio Pulse from Vandana Singh

August 21, 2023 | 6:57 pm

EL

Morgan Stanley analyst Dara Mohsenian has reiterated an Overweight rating on Estee Lauder Companies Inc (NYSE:EL) but lowered the price target from $243 to $200. The cut is due to weaker than expected FY24 EPS guidance and inventory issues in Hainan. The analyst expects a robust recovery as Hainan issues dissipate and believes EL is now trying to guide conservatively.

Portfolio Pulse from Shivani Kumaresan

August 21, 2023 | 6:57 pm

BABA

JD

KWEB

Chinese stocks have been hit hard due to concerns about China's economic growth and surprise rate cuts. China's central bank reduced the lending rate for its 1-year bonds but kept the 5-year bond interest rates steady. Analyst Adam Button sees similarities between China's economic situation and the U.S. crisis of 2008. The uncertainty has led to a sharp decline in a number of Chinese stocks like Alibaba Group (NYSE:BABA), JD.Com Inc (NASDAQ:JD), which are among the holdings in the KraneShares CSI China Internet ETF (NYSE:KWEB).

Portfolio Pulse from Aaron Bry

August 21, 2023 | 6:56 pm

BMY

A significant investor has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY), with 53% of recent trades being bearish. The total amount for puts was $173,984 and for calls was $357,732. The targeted price range for the last 3 months has been $52.5 to $62.5. The current price of BMY is $62.02, down 0.07%. Analysts from Wells Fargo, Atlantic Equities, B of A Securities, Barclays, and BMO Capital have maintained their ratings on BMY, with price targets ranging from $62 to $85.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:46 pm